Background. Hepatocellular carcinoma (HCC) has seen a dramatic rise in the USA over the
last 30 years. Unresectable disease is present in 80–90% of patients, for which …

Purpose To evaluate the long-term outcomes of radiofrequency ablation (RFA) as a first-line
therapy for early-stage hepatocellular carcinoma (HCC) and determine the prognostic …

Abstract. Background and aims: The treatment of choice for hepatocellular carcinoma is
surgical resection. Recurrence occurs in most patients. Aggressive treatment of liver …

Objective: To evaluate our preliminary experience of high-intensity focused ultrasound
(HIFU) for the treatment of recurrent hepatocellular carcinoma (HCC). Background: HIFU is a …

Methods From January 2000 to December 2002, one hundred-sixty patients who had
undergone surgical resection or RFA were analyzed retrospectively. The patients with a …

Objective To evaluate the risk factors affecting early diffuse recurrence within 1 year of
percutaneous ultrasound-guided radiofrequency ablation (RFA) for hepatocellular …

Abstract Background and Aim To determine and compare the adverse events and long‐term
effectiveness for patients with small hepatocellular carcinoma (HCC)(≤ 3 cm) treated by …

For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is
in some centers considered a first-line therapeutic option. However, such a strategy is still …

Objectives. It remains unclear whether radiofrequency ablation (RFA) provides comparable
outcomes to surgical resection (SR). We, therefore, compared survival outcomes of RFA to …

Background Radiofrequency ablation (RFA) is a radical treatment for both primary and
recurrent small hepatocellular carcinoma (HCC) with an optimistic outcome which is …